Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 20 | 2023 | 3598 | 1.460 |
Why?
|
Mutation | 53 | 2023 | 29784 | 1.090 |
Why?
|
Genomics | 13 | 2023 | 5722 | 0.740 |
Why?
|
Genome, Human | 12 | 2020 | 4420 | 0.730 |
Why?
|
Tumor Virus Infections | 2 | 2020 | 452 | 0.730 |
Why?
|
Neoplasms | 19 | 2022 | 21672 | 0.720 |
Why?
|
Phosphatidylinositol 3-Kinases | 11 | 2018 | 2938 | 0.690 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2014 | 2041 | 0.680 |
Why?
|
DNA Mutational Analysis | 21 | 2021 | 4188 | 0.580 |
Why?
|
Computational Biology | 6 | 2020 | 3523 | 0.540 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 4803 | 0.530 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2021 | 1581 | 0.530 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 12 | 2019 | 890 | 0.530 |
Why?
|
Genotype | 12 | 2020 | 12956 | 0.490 |
Why?
|
Carcinoma | 4 | 2019 | 2375 | 0.470 |
Why?
|
DNA Copy Number Variations | 11 | 2019 | 1940 | 0.470 |
Why?
|
Bifidobacterium | 2 | 2003 | 100 | 0.450 |
Why?
|
Adenocarcinoma | 8 | 2018 | 6352 | 0.450 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 477 | 0.440 |
Why?
|
Endometrial Neoplasms | 2 | 2020 | 1353 | 0.430 |
Why?
|
Nucleic Acids | 1 | 2014 | 182 | 0.420 |
Why?
|
Gene Expression Profiling | 13 | 2021 | 9438 | 0.400 |
Why?
|
Genome, Viral | 2 | 2020 | 667 | 0.380 |
Why?
|
Polyomavirus | 2 | 2020 | 248 | 0.340 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2022 | 5221 | 0.340 |
Why?
|
Lung Neoplasms | 7 | 2022 | 13096 | 0.330 |
Why?
|
Arenavirus | 1 | 2008 | 7 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2018 | 1692 | 0.320 |
Why?
|
PTEN Phosphohydrolase | 3 | 2020 | 1143 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 12 | 2022 | 17449 | 0.300 |
Why?
|
Histiocytosis, Langerhans-Cell | 3 | 2015 | 171 | 0.300 |
Why?
|
DNA-Binding Proteins | 7 | 2019 | 9647 | 0.290 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1587 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2022 | 4033 | 0.280 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1814 | 0.280 |
Why?
|
Oncogenes | 8 | 2017 | 1265 | 0.280 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2015 | 337 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2018 | 2948 | 0.270 |
Why?
|
Gene Dosage | 6 | 2018 | 1251 | 0.270 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 426 | 0.260 |
Why?
|
Tumor Suppressor Proteins | 5 | 2012 | 2848 | 0.260 |
Why?
|
Medical Oncology | 2 | 2023 | 2265 | 0.260 |
Why?
|
Genetic Testing | 3 | 2022 | 3443 | 0.250 |
Why?
|
Subtraction Technique | 1 | 2008 | 525 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 379 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2017 | 8426 | 0.240 |
Why?
|
Nuclear Proteins | 9 | 2022 | 5853 | 0.240 |
Why?
|
Micrococcal Nuclease | 1 | 2003 | 37 | 0.240 |
Why?
|
Ovarian Neoplasms | 6 | 2018 | 4837 | 0.240 |
Why?
|
DNA Helicases | 4 | 2022 | 861 | 0.240 |
Why?
|
Colorectal Neoplasms | 4 | 2021 | 6773 | 0.230 |
Why?
|
Uterine Neoplasms | 3 | 2018 | 1513 | 0.230 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 212 | 0.230 |
Why?
|
Genes, Tumor Suppressor | 4 | 2018 | 1097 | 0.230 |
Why?
|
Transcription Factors | 9 | 2022 | 12207 | 0.230 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2014 | 100 | 0.220 |
Why?
|
Polyomavirus Infections | 2 | 2020 | 197 | 0.220 |
Why?
|
Humans | 94 | 2023 | 744220 | 0.220 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 2 | 2016 | 199 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4553 | 0.220 |
Why?
|
Serine | 1 | 2006 | 828 | 0.220 |
Why?
|
Osteosarcoma | 2 | 2023 | 881 | 0.210 |
Why?
|
Genetic Complementation Test | 1 | 2003 | 562 | 0.210 |
Why?
|
Skin Neoplasms | 6 | 2021 | 5670 | 0.210 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2006 | 671 | 0.210 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2020 | 300 | 0.200 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 224 | 0.190 |
Why?
|
Nevus | 1 | 2023 | 204 | 0.190 |
Why?
|
Gene Amplification | 4 | 2023 | 1062 | 0.190 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1596 | 0.190 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3703 | 0.190 |
Why?
|
Indoles | 4 | 2014 | 1838 | 0.180 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2019 | 323 | 0.180 |
Why?
|
Polymerase Chain Reaction | 3 | 2017 | 6172 | 0.180 |
Why?
|
Bacterial Proteins | 2 | 2003 | 3849 | 0.180 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3921 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2020 | 15525 | 0.170 |
Why?
|
ras Proteins | 3 | 2014 | 1060 | 0.170 |
Why?
|
Sulfonamides | 4 | 2014 | 1940 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.170 |
Why?
|
Mullerian Ducts | 2 | 2018 | 198 | 0.170 |
Why?
|
Melanoma | 5 | 2023 | 5475 | 0.170 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 210 | 0.170 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 233 | 0.170 |
Why?
|
Adnexal Diseases | 1 | 2019 | 102 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 193 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 5 | 2021 | 5529 | 0.160 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 565 | 0.160 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.160 |
Why?
|
Pituitary Neoplasms | 2 | 2017 | 1346 | 0.160 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14726 | 0.160 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2019 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2014 | 736 | 0.160 |
Why?
|
Virus Integration | 1 | 2020 | 299 | 0.160 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 805 | 0.150 |
Why?
|
Aged, 80 and over | 19 | 2021 | 57768 | 0.150 |
Why?
|
Adenoma | 2 | 2019 | 2174 | 0.150 |
Why?
|
Aged | 31 | 2021 | 163253 | 0.150 |
Why?
|
Tennessee | 1 | 2017 | 117 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 601 | 0.150 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.150 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2003 | 1123 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2021 | 1660 | 0.150 |
Why?
|
Female | 46 | 2023 | 380197 | 0.140 |
Why?
|
Signal Transduction | 9 | 2018 | 23404 | 0.140 |
Why?
|
Chromosomes, Human | 2 | 2016 | 457 | 0.140 |
Why?
|
Genes, ras | 4 | 2016 | 690 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9230 | 0.140 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1333 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 332 | 0.140 |
Why?
|
Mesonephroma | 1 | 2015 | 16 | 0.140 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2525 | 0.140 |
Why?
|
Frameshift Mutation | 2 | 2018 | 399 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 545 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1149 | 0.130 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2015 | 58 | 0.130 |
Why?
|
Middle Aged | 33 | 2021 | 213367 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2018 | 5169 | 0.130 |
Why?
|
Ovarian Cysts | 1 | 2016 | 115 | 0.130 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3772 | 0.130 |
Why?
|
Papillomaviridae | 2 | 2018 | 1119 | 0.120 |
Why?
|
Prognosis | 10 | 2023 | 29050 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 989 | 0.120 |
Why?
|
Adenosarcoma | 1 | 2014 | 34 | 0.120 |
Why?
|
Adult | 32 | 2022 | 214035 | 0.120 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2014 | 9 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 281 | 0.120 |
Why?
|
Brain Neoplasms | 5 | 2017 | 8860 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 704 | 0.120 |
Why?
|
Facial Dermatoses | 1 | 2014 | 87 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 522 | 0.120 |
Why?
|
Gene Fusion | 1 | 2017 | 371 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 77 | 0.120 |
Why?
|
Head and Neck Neoplasms | 2 | 2018 | 2732 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2012 | 647 | 0.120 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 272 | 0.120 |
Why?
|
Sequence Analysis | 1 | 2014 | 256 | 0.120 |
Why?
|
Survival Analysis | 4 | 2020 | 10250 | 0.120 |
Why?
|
Comparative Genomic Hybridization | 4 | 2017 | 496 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 57 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 324 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2649 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13668 | 0.110 |
Why?
|
Germ-Line Mutation | 3 | 2022 | 1787 | 0.110 |
Why?
|
Phylogeny | 1 | 2020 | 2803 | 0.110 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 20 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2014 | 376 | 0.110 |
Why?
|
Male | 32 | 2022 | 350027 | 0.110 |
Why?
|
Chromosome Deletion | 2 | 2014 | 1401 | 0.110 |
Why?
|
Glioma | 3 | 2013 | 3401 | 0.110 |
Why?
|
Muscle Neoplasms | 1 | 2013 | 139 | 0.100 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2012 | 462 | 0.100 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2016 | 505 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2023 | 20817 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 291 | 0.100 |
Why?
|
Colonic Neoplasms | 2 | 2016 | 2538 | 0.100 |
Why?
|
Ovary | 1 | 2016 | 981 | 0.100 |
Why?
|
Cadherins | 1 | 2016 | 907 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19907 | 0.100 |
Why?
|
Chordoma | 1 | 2014 | 359 | 0.100 |
Why?
|
Sarcoma | 1 | 2022 | 1897 | 0.100 |
Why?
|
Genes, myc | 1 | 2012 | 399 | 0.100 |
Why?
|
raf Kinases | 1 | 2011 | 122 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 503 | 0.090 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2014 | 450 | 0.090 |
Why?
|
Pons | 1 | 2011 | 245 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4752 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 725 | 0.090 |
Why?
|
Biopsy | 4 | 2018 | 6757 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 665 | 0.090 |
Why?
|
Uveal Neoplasms | 1 | 2012 | 310 | 0.090 |
Why?
|
Angiomyolipoma | 1 | 2011 | 190 | 0.090 |
Why?
|
Genome | 2 | 2009 | 1808 | 0.090 |
Why?
|
Prostatectomy | 1 | 2018 | 1887 | 0.090 |
Why?
|
Inheritance Patterns | 1 | 2012 | 340 | 0.090 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2010 | 101 | 0.090 |
Why?
|
Brain Stem Neoplasms | 1 | 2011 | 204 | 0.090 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 183 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 731 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1860 | 0.080 |
Why?
|
Wolffian Ducts | 2 | 2019 | 23 | 0.080 |
Why?
|
Databases, Genetic | 3 | 2016 | 1782 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 684 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3461 | 0.080 |
Why?
|
DNA Primers | 2 | 2011 | 2892 | 0.080 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2011 | 207 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 783 | 0.080 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11007 | 0.080 |
Why?
|
Cohort Studies | 8 | 2021 | 40559 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1987 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2012 | 526 | 0.080 |
Why?
|
Cell Line, Tumor | 10 | 2014 | 16687 | 0.080 |
Why?
|
Codon | 1 | 2009 | 611 | 0.080 |
Why?
|
Genetic Variation | 2 | 2017 | 6546 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2011 | 484 | 0.070 |
Why?
|
Gene Deletion | 2 | 2013 | 2751 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 211 | 0.070 |
Why?
|
Protein Methyltransferases | 1 | 2006 | 55 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2013 | 2503 | 0.070 |
Why?
|
Astrocytoma | 1 | 2011 | 789 | 0.070 |
Why?
|
Telomere | 1 | 2012 | 910 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3557 | 0.070 |
Why?
|
DNA, Neoplasm | 3 | 2020 | 1758 | 0.070 |
Why?
|
Tumor Burden | 2 | 2022 | 1914 | 0.070 |
Why?
|
HL-60 Cells | 1 | 2006 | 365 | 0.070 |
Why?
|
Mutation, Missense | 2 | 2012 | 2563 | 0.070 |
Why?
|
Phenotype | 4 | 2018 | 16365 | 0.070 |
Why?
|
Young Adult | 9 | 2022 | 56436 | 0.070 |
Why?
|
Genetic Markers | 1 | 2012 | 2634 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1221 | 0.060 |
Why?
|
Mass Spectrometry | 4 | 2014 | 2204 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3086 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 945 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.060 |
Why?
|
Embryonic Development | 1 | 2009 | 711 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2009 | 851 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2022 | 11368 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2007 | 435 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4440 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2038 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9311 | 0.060 |
Why?
|
DNA Damage | 3 | 2012 | 2432 | 0.060 |
Why?
|
Meningioma | 1 | 2013 | 1209 | 0.060 |
Why?
|
beta Catenin | 2 | 2023 | 1059 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2867 | 0.060 |
Why?
|
Alleles | 3 | 2013 | 6938 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5216 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 893 | 0.060 |
Why?
|
Paraffin Embedding | 2 | 2017 | 299 | 0.060 |
Why?
|
Phosphorylation | 3 | 2015 | 8437 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4216 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15070 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2924 | 0.060 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2014 | 140 | 0.060 |
Why?
|
Protein Sorting Signals | 1 | 2003 | 281 | 0.060 |
Why?
|
Zebrafish Proteins | 1 | 2009 | 1004 | 0.060 |
Why?
|
Social Class | 1 | 2012 | 1999 | 0.050 |
Why?
|
Formaldehyde | 2 | 2017 | 353 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 18116 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 8986 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1582 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6535 | 0.050 |
Why?
|
Prospective Studies | 5 | 2022 | 53280 | 0.050 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 188 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11074 | 0.050 |
Why?
|
Amino Acid Substitution | 3 | 2012 | 1792 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2600 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1731 | 0.050 |
Why?
|
Protein Conformation | 1 | 2009 | 4012 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2015 | 508 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 13885 | 0.050 |
Why?
|
Child, Preschool | 7 | 2022 | 40992 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2501 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2281 | 0.050 |
Why?
|
Base Sequence | 3 | 2013 | 12801 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15226 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2022 | 2727 | 0.040 |
Why?
|
Child | 9 | 2022 | 77679 | 0.040 |
Why?
|
Exons | 2 | 2019 | 2439 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6893 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2014 | 3614 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2505 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7908 | 0.040 |
Why?
|
Research Design | 2 | 2012 | 5987 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4742 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12781 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12264 | 0.040 |
Why?
|
Transfection | 1 | 2006 | 5892 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2014 | 2915 | 0.040 |
Why?
|
Infant | 5 | 2022 | 35129 | 0.040 |
Why?
|
Protein Binding | 2 | 2009 | 9392 | 0.040 |
Why?
|
Zebrafish | 1 | 2009 | 2994 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 602 | 0.040 |
Why?
|
Adolescent | 7 | 2022 | 85759 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1989 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 631 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2006 | 2422 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3646 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3494 | 0.040 |
Why?
|
Introns | 1 | 2019 | 991 | 0.040 |
Why?
|
Databases, Factual | 1 | 2012 | 7730 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2012 | 3158 | 0.040 |
Why?
|
Chromogranins | 1 | 2017 | 163 | 0.040 |
Why?
|
Pedigree | 2 | 2016 | 4648 | 0.030 |
Why?
|
Cell Lineage | 2 | 2018 | 2504 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1179 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 684 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2018 | 11478 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9582 | 0.030 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 202 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
Hong Kong | 1 | 2015 | 148 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1525 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 77426 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4245 | 0.030 |
Why?
|
BALB 3T3 Cells | 1 | 2014 | 9 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2018 | 312 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2216 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1255 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 188 | 0.030 |
Why?
|
Uterus | 1 | 2018 | 710 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 981 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2416 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2702 | 0.030 |
Why?
|
Langerhans Cells | 1 | 2014 | 173 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2226 | 0.030 |
Why?
|
Software | 1 | 2007 | 4442 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 161 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 371 | 0.030 |
Why?
|
Valine | 1 | 2014 | 413 | 0.030 |
Why?
|
Disease Progression | 3 | 2016 | 13280 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2012 | 18 | 0.030 |
Why?
|
Animals | 7 | 2014 | 168788 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 75 | 0.030 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 267 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 194 | 0.030 |
Why?
|
Apoptosis | 3 | 2016 | 9728 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13817 | 0.020 |
Why?
|
Phosphatidylethanolamine Binding Protein | 1 | 2011 | 11 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1101 | 0.020 |
Why?
|
Social Identification | 1 | 2012 | 103 | 0.020 |
Why?
|
Cell Cycle | 2 | 2010 | 2967 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2011 | 169 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 159 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1724 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 19227 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2018 | 1548 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2012 | 4841 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 712 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 199 | 0.020 |
Why?
|
Sezary Syndrome | 1 | 2011 | 76 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 118 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2012 | 209 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2014 | 1097 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 3023 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1102 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 390 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2016 | 975 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 295 | 0.020 |
Why?
|
Niacinamide | 1 | 2011 | 416 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10480 | 0.020 |
Why?
|
Mycosis Fungoides | 1 | 2011 | 163 | 0.020 |
Why?
|
Genes, jun | 1 | 2008 | 71 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2012 | 404 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1169 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39045 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 13036 | 0.020 |
Why?
|
Plasma Cells | 1 | 2012 | 591 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2011 | 527 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2700 | 0.020 |
Why?
|
Mice | 5 | 2014 | 81178 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2022 | 25618 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1508 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1677 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 695 | 0.020 |
Why?
|
Culture | 1 | 2012 | 633 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 635 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 676 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2015 | 7879 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6313 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2012 | 594 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 742 | 0.020 |
Why?
|
Prejudice | 1 | 2012 | 570 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2010 | 437 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 625 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2715 | 0.020 |
Why?
|
Cell Size | 1 | 2009 | 643 | 0.020 |
Why?
|
Telomerase | 1 | 2012 | 729 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2726 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3689 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1849 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 894 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3129 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3846 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 942 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 567 | 0.020 |
Why?
|
Mutagenesis | 1 | 2009 | 1267 | 0.020 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 516 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2007 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4201 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2009 | 809 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 577 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2942 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12961 | 0.020 |
Why?
|
Health Services Research | 1 | 2012 | 1836 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13409 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1782 | 0.010 |
Why?
|
DNA Repair | 1 | 2012 | 2046 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12244 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 72280 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12355 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
Genetic Loci | 1 | 2010 | 2575 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 2940 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2009 | 2069 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5881 | 0.010 |
Why?
|
Pyridines | 1 | 2011 | 2822 | 0.010 |
Why?
|
Proteome | 1 | 2008 | 1798 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7784 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10396 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3508 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4252 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18027 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63119 | 0.010 |
Why?
|